A multicenter, open-label study on the efficacy, cycle control and safety of a contraceptive vaginal ring delivering a daily dose of 150 Ug of Nestorone [elcometrine] and 15 Ug of ethinyl estradiol.

Trial Profile

A multicenter, open-label study on the efficacy, cycle control and safety of a contraceptive vaginal ring delivering a daily dose of 150 Ug of Nestorone [elcometrine] and 15 Ug of ethinyl estradiol.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Nov 2017

At a glance

  • Drugs Estradiol/elcometrine (Primary)
  • Indications Pregnancy
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 01 Nov 2017 Results assessing acceptability and adherence to use of the Nestorone /Ethinylestradiol presented at the American Society for Reproductive Medicine Scientific Congress 2017
    • 27 Sep 2017 Status changed from active, no longer recruiting to completed.
    • 22 Sep 2015 Sub-study results published in the Contraception.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top